---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Tazemetostat Hydrobromide - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/tazemetostathydrobromide
version: v1
---

# Tazemetostat Hydrobromide - NCI

# Tazemetostat Hydrobromide

Placeholder slot

(TA-zeh-MEH-toh-stat HY-droh-BROH-mide)

This page contains brief information about tazemetostat hydrobromide
and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Tazverik

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=7db07b5f-4e22-467c-9c0a-f830b08dbb1d&audience=consumer)

## Use in Cancer

Tazemetostat hydrobromide
is approved to treat:

- **[Epithelioid sarcoma](/Common/PopUps/popDefinition.aspx?id=782481&version=Patient&language=English)** that is [locally advanced](/Common/PopUps/popDefinition.aspx?id=45955&version=Patient&language=English) or has [metastasized](/Common/PopUps/popDefinition.aspx?id=46283&version=Patient&language=English) (spread to other parts of the body). It is used in adults and in children aged 16 years and older whose disease cannot be removed by [surgery](/Common/PopUps/popDefinition.aspx?id=45570&version=Patient&language=English).¹
- **[Follicular lymphoma](/Common/PopUps/popDefinition.aspx?id=428287&version=Patient&language=English)** that has [relapsed](/Common/PopUps/popDefinition.aspx?id=45866&version=Patient&language=English) (come back) or is [refractory](/Common/PopUps/popDefinition.aspx?id=45863&version=Patient&language=English) (does not respond to treatment). It is used in adults:
- Whose [tumors](/Common/PopUps/popDefinition.aspx?id=46634&version=Patient&language=English) have a certain [mutation](/Common/PopUps/popDefinition.aspx?id=46063&version=Patient&language=English) in the *[EZH2](/Common/PopUps/popDefinition.aspx?id=801889&version=Patient&language=English)* [gene](/Common/PopUps/popDefinition.aspx?id=45693&version=Patient&language=English) and who have received at least two [systemic therapies](/Common/PopUps/popDefinition.aspx?id=45922&version=Patient&language=English).¹
- Who are not able to receive other therapies.¹

¹This use is approved under FDA’s [Accelerated Approval Program](https://www.fda.gov/ForPatients/Approvals/Fast/ucm405447.htm). As a condition of approval, [confirmatory trial(s)](/Common/PopUps/popDefinition.aspx?id=799146&version=Patient&language=English) must show that tazemetostat hydrobromide provides a clinical benefit in these patients.

Tazemetostat hydrobromide
is also being studied in the treatment of other types of
[cancer](/Common/PopUps/popDefinition.aspx?id=45333&version=Patient&language=English).

## More About Tazemetostat Hydrobromide

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/751383) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Tazemetostat Hydrobromide](https://medlineplus.gov/druginfo/meds/a620018.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Cancer Therapies](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Tazemetostat Hydrobromide](https://www.cancer.gov/research/participate/clinical-trials/intervention/C166954) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
